By Gina Lee

Investing.com – Asia Pacific stocks were down on Tuesday morning, even as Australia released.

Japan’s slid 1.28% by 9:02 PM ET (2:02 AM GMT), re-opening after a holiday. South Korea’s was down 0.44%.

Australia saw a 0.85% decrease in the number of people living there, and a 7.3% increase month over month. This was approximately AUD9.423 million.

Hong Kong’s was down 0.50%.

China’s edged down 0.12% and the was down 0.29%. On Wednesday, the country will publish its price and indexes.

Investors continue to monitor the impact of central banks’ tightening of their monetary policies and the spread of the omicron COVID-19 variant.

“We think eventually this market will shift back toward growth, but we still got some wood to chop there; the valuations haven’t corrected,” RBC Capital Markets head of U.S. equity strategy Lori Calvasina told Bloomberg.

“This is a repricing, it’s painful, it has a little bit more ways to go.”

U.S. Treasury yields flattened as short-dated yields rose sharply. This was due to increased bets for a U.S. Federal Reserve rate hike in February 2022. Goldman Sachs Group Inc. also predicted that there would be four more hikes in 2022.

Jerome Powell of the U.S. Federal Reserve stated the U.S. economic expansion was rapid and that higher inflation will be prevented by the central bank. He made this statement ahead of his confirmation hearing to serve as Senate Chairman. Powell warned that the post COVID-19 world could differ from previous ones.

A hearing will be held by the U.S. Senate Banking Committee on Thursday for Lael brainard, Fed vice chair nominee. The Kansas City Fed President Esther George, and St. Louis Fed President James Bullard are also scheduled to speak during the day.

The U.S. will publish the the Wednesday before the Thursday.

Giving investor sentiment a boost, however, New York’s virus infections may have reached a peak around a month after the first omicron case was identified in the area. Pfizer Inc. (NYSE:) is also developing a hybrid vaccine that shields against the omicron variant and a new study from Imperial College London showed protective immune “t-cells” triggered by the common cold lessened the chances of contracting COVID-19.